Latest Aortic valve replacement Stories
Study finds novel procedure comparable to open-heart surgery for high-risk seniors Two-year data show comparable death and durability for catheter-placed heart valves and open-heart surgery in very old and ill patients, according to research presented today at the American College of Cardiology's 61st Annual Scientific Session. The Scientific Session, the premier cardiovascular medical meeting, brings cardiovascular professionals together to further advances in the field. An estimated 5...
Patients diagnosed with aortic stenosis who are too sick for open-heart surgery have better survival rates and an improved quality of life after undergoing catheter-based heart valve replacement than if the patients had been treated with standard medical therapy, according to a study authored by a Cedars-Sinai Heart Institute physician based on results from a multicenter clinical trial. The study, published online today by the New England Journal of Medicine, will appear in the May 3 print...
SCAI, AATS, ACCF, and STS offer facility and operator criteria to ensure optimal care of TAVR patients Four leading heart organizations representing cardiologists and cardiothoracic surgeons released initial recommendations today for creating and maintaining transcatheter aortic valve replacement (TAVR) programs. The recommendations are aimed at ensuring optimal care for patients with aortic stenosis, a form of valvular heart disease, as use of the new TAVR procedure grows. Since the...
Procedure Brings a Treatment Option for Patients with Severe Aortic Stenosis CLEARWATER, Fla., Feb. 9, 2012 /PRNewswire-USNewswire/ -- Morton Plant Hospital continues its legacy as a leader in heart care by performing the first transcatheter aortic valve replacement surgery (TAVR) in the Tampa Bay area. A treatment for severe aortic stenosis, the TAVR procedure is used for patients who were previously considered inoperable. The first two TAVR procedures...
Leading medical groups collaborate to ensure consistent, responsible uptake of TAVR With the U.S. Food and Drug Administration's recent approval of transcatheter aortic valve replacement (TAVR) for patients with aortic valvular stenosis, the American College of Cardiology Foundation (ACCF), along with the American Association for Thoracic Surgery (AATS), the Society for Cardiovascular Angiography and Interventions (SCAI) and the Society of Thoracic Surgeons (STS), today released an expert...
LEESBURG, Fla., Jan. 26, 2012 /PRNewswire/ -- Yesterday, Leesburg Regional's renowned heart surgeons and cardiologists performed two successful Transcatheter Aortic Valve Implantations (TAVI). These are the first and only procedures done to date in Central Florida. This new treatment option is for patients with severe, symptomatic native aortic valve stenosis and who have been determined by a cardiac surgeon to be inoperable for open aortic valve replacement. It is currently a...
CHICAGO, Jan. 9, 2012 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Edwards Lifesciences (NYSE: EW), Medtronic (NYSE: MDT), Boston Scientific Corporation (NYSE: BSX), St Jude Medical (NYSE: STJ) and Johnson & Johnson (NYSE: JNJ). (Logo:...
SILVER SPRING, Md., Nov. 2, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved the first artificial heart valve that can replace an aortic heart valve damaged by senile aortic valve stenosis without open-heart surgery. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) Senile aortic valve stenosis is a progressive, age-related disease caused by calcium deposits on the aortic valve that cause the valve to narrow. As the heart works harder to pump...
